Please login to the form below
MDR
This page shows the latest MDR news and features for those working in and with pharma, biotech and healthcare.
FDA green lights study of phage-based drug for resistant infections
One company working in this area – Adaptive Phage Therapeutics – has just won FDA approval to start human testing of personalised bacteriophage therapeutics for serious MDR infections. ... strain. Arms of the study will also focus on specific bacteria
Latest news
-
Merck preps regulatory filings for much-needed antibiotic combo
An independent UK review estimated that by 2050 MDR infections could claim 10 million lives a year and result in a cumulative loss from global output of $100trn. ... rates of multidrug resistant (MDR) strains, the need for new treatment options is
-
Pharma must do more on antibiotic resistance, Davos meeting hears
In particular, more needs to be done to bring forward new drugs for multidrug resistant (MDR) pathogens or ‘superbugs’ - there are currently 28 novel drugs for high-priority pathogens in phase
-
Pfizer launches antibiotic resistance surveillance website
Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn
-
Pfizer launches new antibiotic Zavicefta in UK and Germany
MDR infections are an increasing global threat," said Matteo Bassetti, chief of the infectious diseases Clinic at University of Udine in Italy. ... The availability of Zavicefta is a major step forward for physicians faced with the challenge of treating
-
AZ slims down again with sale of antibiotics to Pfizer
ATM-AVI is in trials for life-threatening Gram-negative bacterial infections caused by multi-drug resistant (MDR) strains, while CXL has activity against MDR Gram-positive and Gram-negative pathogens.
More from news
Approximately 4 fully matching, plus 27 partially matching documents found.
Latest Intelligence
-
Medical device regulation - a risk-based approach to compliance
Simply put, complying with MDR is another stressor for medtechs at an already challenging time, potentially affecting both top- and bottom-line growth. ... It's difficult to estimate just how great the costs associated with MDR implementation will
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
Medical Device Clinical Trials 2020
In this session, we heard from Bassil Akra, CEO of QUnique Group, who gave us a quick overview of the EU MDR. ... We’re pleased to hear that not only the pharma industry will benefit from the EU MDR, but there will be positive changes for patients too.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- UK pharmacies to begin administering COVID-19 vaccinations
- New study identifies drugs that are safe to use in COVID-19 treatment
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Onyx Health Celebrates Its 10th Anniversary with Five New Hires
- Merck’s appeal to restore hepatitis C patent verdict against Gilead fails
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Trial combining British and Russian COVID-19 vaccines could begin in February
- New Oxford research institute established to tackle antimicrobial resistance
- EU proposes vaccine-sharing mechanism with low-income countries
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- Recent years have seen a significant shift in drug development to specialty areas...
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
Quick links
Infographics
